Back to Hypogonadotropic Hypogonadism 7 With or Without Anosmia

Hypogonadotropic Hypogonadism 7 With or Without Anosmia — Clinical Trials

MONDO:00077943 active·2 recruitingLast updated: Mar 18, 2026, 6:43 PM

Trial Landscape

Hypogonadotropic Hypogonadism 7 With or Without Anosmia has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

By Approach

Drug Treatment3

By Phase

Phase 2

Phase 3

1 trials are observational or have no phase designation.

Sponsor Types

Academic/Other2Industry1

Top Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd.

Trial Locations

China2 trials

United States1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT05896293

Kisspeptin Administration Subcutaneously to Patients With IHH

Sponsor:Stephanie B. Seminara, MD

United StatesStarted: Feb 2023Est. completion: May 2028Updated: Oct 2025

Not ApplicableRecruiting

NCT05569577

An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients

Sponsor:Fudan University

ChinaStarted: Jan 2021Est. completion: Dec 2025Updated: Aug 2024

Last updated over 18 months ago

Phase 3Not Yet Recruiting

NCT06561594

To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection

Sponsor:Changchun GeneScience Pharmaceutical Co., Ltd.

ChinaStarted: Sep 2024Est. completion: Dec 2026Updated: Aug 2024

Last updated over 18 months ago

Stay informed about clinical trials for Hypogonadotropic Hypogonadism 7 With or Without Anosmia.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 18, 2026 at 6:43 PM